Series date: 
01/01/2020 - 7:00am to 12/31/2020 - 8:00am

Mayo Clinic is committed to taking care of our learners and staff as we address the COVID-19 situation. In order to help protect our communities, and out of an abundance of caution, the School of Continuous Professional Development (CPD) is suspending live courses and conferences through December 31, 2020.

At this time, CPD suggests suspending or changing delivery method for Regularly Scheduled Series (RSS) with more than 10 in-person attendees. See individual RSS sessions for any changes to dates, times and delivery methods.

DESCRIPTION
Conferences take place on Tuesday mornings at 7:00 am - 8:00 am. Exceptions will be noted in the weekly notification.

TARGET AUDIENCE
This course is intended primarily for Pain Medicine Fellows, Anesthesiology Residents, Staff MDs, and PAs.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

  • Identify the latest evidence based approach for interventional pain procedures.
  • Identify the latest innovative pain procedures that are available for patient care.
  • Summarize the most recent evidence based support for pharmacologic management for chronic pain. 

ACCREDITATION STATEMENT



In support of improving patient care, Mayo Clinic College of Medicine and Science is jontly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 
 

Credit Statement(s):
AMA

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with industry: 
None

No relevant financial relationship(s) with industry: 
John Freeman, D.O.
Deborah Torres
Christopher Wie, M.D.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

COURSE DIRECTORS
Christopher Wie MD and John Freeman DO

QUESTIONS?
Contact Deborah Torres, Department Coordinator, at Torres.Deborah@mayo.edu

Where did the idea for the course originate?: 
Arizona